Table 3.
Stability estimates in key components of stress reactivity across 18-month follow-up as a function of youth genetic susceptibility.
| Test-retest correlations for each stress reactivity component | |||||
| Genotype | Lab entry | Baseline | Challenge | Recovery 1 | Recovery 2 |
|
| |||||
| 5-HTTLPR | |||||
| LL | .15 | .06 | .02 | .27* | .13 |
| SL/SS | .43*** | .18* | .60*** | .49*** | .21* |
| DRD2 | |||||
| A1A1/A1A2 | .31* | .16 | .25* | .41*** | .22* |
| A2A2 | .37*** | .17* | .47*** | .47*** | .17* |
| COMT | |||||
| Met | .05 | .00 | .05 | .17 | .38** |
| V/V;V/M | .45*** | .20* | .56*** | .49*** | .47*** |
| CRHR1 rs242924 | |||||
| AC/CC | .29*** | .14 | .22** | .17* | .14 |
| AA | .25 | .33* | .72*** | .15 | .13 |
| CRHR1 rs878886 | |||||
| GG | .14 | .14 | .36*** | .06 | .06 |
| CC/CG | .65*** | .30* | .28* | .44*** | .40** |